Safety of Expanded Haploidentical Natural Killer Cells for Leukemia
Clinical trial NCT04327037 · COMPLETED
Trial details
- NCT number
- NCT04327037
- Sponsor
- Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2021-06-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.